[Immunohistochemical analysis for cholangiocarcinoma].
Nakagoe
Tohru
T
Department of Surgery, Ohmura Municipal Hospital.
Matsuo
Toshikazu
T
Kondoh
Masamichi
M
Yamaguchi
Hiroyuki
H
D015295:Antigens, Tumor-Associated, Carbohydrate / Q000032:analysis; D001650:Bile Duct Neoplasms / Q000175:diagnosis*; D001653:Bile Ducts, Intrahepatic; D014408:Biomarkers, Tumor / Q000032:analysis*; D018395:CA-19-9 Antigen / Q000032:analysis; D002272:Carcinoembryonic Antigen / Q000032:analysis; D018281:Cholangiocarcinoma / Q000175:diagnosis*; D006801:Humans; D007150:Immunohistochemistry; D007633:Keratins / Q000032:analysis; D009844:Oligosaccharides / Q000032:analysis; D011379:Prognosis; D000080506:Sialyl Lewis X Antigen; D000509:alpha-Fetoproteins / Q000032:analysis
D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor; D018395:CA-19-9 Antigen; D002272:Carcinoembryonic Antigen; D009844:Oligosaccharides; D000080506:Sialyl Lewis X Antigen; D000509:alpha-Fetoproteins; C055491:sialosyl-Tn antigen; D007633:Keratins